Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reproducible Reporting of the Collection and Evaluation of Annotations for Artificial Intelligence Models.
Elfer K, Gardecki E, Garcia V, Ly A, Hytopoulos E, Wen S, Hanna MG, Peeters DJE, Saltz J, Ehinger A, Dudgeon SN, Li X, Blenman KRM, Chen W, Green U, Birmingham R, Pan T, Lennerz JK, Salgado R, Gallas BD. Elfer K, et al. Among authors: salgado r. Mod Pathol. 2024 Apr;37(4):100439. doi: 10.1016/j.modpat.2024.100439. Epub 2024 Jan 28. Mod Pathol. 2024. PMID: 38286221 Free article.
Training pathologists to assess stromal tumour-infiltrating lymphocytes in breast cancer synergises efforts in clinical care and scientific research.
Ly A, Garcia V, Blenman KRM, Ehinger A, Elfer K, Hanna MG, Li X, Peeters DJE, Birmingham R, Dudgeon S, Gardecki E, Gupta R, Lennerz J, Pan T, Saltz J, Wharton KA Jr, Ehinger D, Acs B, Dequeker EMC, Salgado R, Gallas BD. Ly A, et al. Among authors: salgado r. Histopathology. 2024 May;84(6):915-923. doi: 10.1111/his.15140. Epub 2024 Mar 3. Histopathology. 2024. PMID: 38433289 Review.
Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML.
Lennerz JK, Salgado R, Kim GE, Sirintrapun SJ, Thierauf JC, Singh A, Indave I, Bard A, Weissinger SE, Heher YK, de Baca ME, Cree IA, Bennett S, Carobene A, Ozben T, Ritterhouse LL. Lennerz JK, et al. Among authors: salgado r. Clin Chem Lab Med. 2023 Jan 25;61(4):544-557. doi: 10.1515/cclm-2022-1151. Print 2023 Mar 28. Clin Chem Lab Med. 2023. PMID: 36696602 Free article.
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial.
Sharma P, Stecklein SR, Yoder R, Staley JM, Schwensen K, O'Dea A, Nye L, Satelli D, Crane G, Madan R, O'Neil MF, Wagner J, Larson KE, Balanoff C, Kilgore L, Phadnis MA, Godwin AK, Salgado R, Khan QJ, O'Shaughnessy J. Sharma P, et al. Among authors: salgado r. JAMA Oncol. 2024 Feb 1;10(2):227-235. doi: 10.1001/jamaoncol.2023.5033. JAMA Oncol. 2024. PMID: 37991778 Free PMC article. Clinical Trial.
Development of a deep-learning model tailored for HER2 detection in breast cancer to aid pathologists in interpreting HER2-low cases.
Bannier PA, Broeckx G, Herpin L, Dubois R, Van Praet L, Maussion C, Deman F, Amonoo E, Mera A, Timbres J, Gillett C, Sawyer E, Gazińska P, Ziolkowski P, Lacroix-Triki M, Salgado R, Irshad S. Bannier PA, et al. Among authors: salgado r. Histopathology. 2024 Sep;85(3):478-488. doi: 10.1111/his.15274. Epub 2024 Jul 14. Histopathology. 2024. PMID: 39004603
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
Wang Y, Dackus GMHE, Rosenberg EH, Cornelissen S, de Boo LW, Broeks A, Brugman W, Chan TWS, van Diest PJ, Hauptmann M, Ter Hoeve ND, Isaeva OI, de Jong VMT, Jóźwiak K, Kluin RJC, Kok M, Koop E, Nederlof PM, Opdam M, Schouten PC, Siesling S, van Steenis C, Voogd AC, Vreuls W, Salgado RF, Linn SC, Schmidt MK. Wang Y, et al. BMC Med. 2024 Jan 9;22(1):9. doi: 10.1186/s12916-023-03233-7. BMC Med. 2024. PMID: 38191387 Free PMC article.
629 results